[abstract] A 10-YEAR RETROSPECTIVE STUDY OF THE EFFECTIVENESS OF HYPERBARIC OXYGEN THERAPY IN TREATING CRITICALLY ILL PEDIATRIC PATIENTS.

Rubicon Research Repository/Manakin Repository

[abstract] A 10-YEAR RETROSPECTIVE STUDY OF THE EFFECTIVENESS OF HYPERBARIC OXYGEN THERAPY IN TREATING CRITICALLY ILL PEDIATRIC PATIENTS.

Show simple item record


dc.contributor.author Yu, T
dc.contributor.author Poon, C
dc.contributor.author Moore, P
dc.contributor.author Terry, M
dc.contributor.author Gold, P
dc.contributor.author Lo, T
dc.date.accessioned 2008-10-29T14:04:22Z
dc.date.available 2008-10-29T14:04:22Z
dc.date.issued 2008
dc.identifier.citation Undersea Hyperb Med. 2008 July-Aug;35(4) en
dc.identifier.issn 1066-2936
dc.identifier.uri http://archive.rubicon-foundation.org/7841
dc.description Abstract of the Undersea & Hyperbaric Medical Society 2008 Annual Scientific Meeting June 26-28, 2008 Salt Lake City Marriott Downtown, Salt Lake City, Utah. en
dc.description.abstract BACKGROUND & AIMS: Hyperbaric oxygen therapy (HBOT) is effective in treating numerous medical conditions including: air embolism, decompression illness, carbon monoxide poisoning, problem wounds and refractory osteomyelitis. No study has explicitly examined the effective use of HBOT in healing critically ill pediatric patients with indication for HBOT. METHODS: A retrospective chart review of patients treated with HBOT from 1995-2004 in our monoplace chambers was conducted. Our operation is entirely supervised by critical care/pulmonary medicine physicians and performed by licensed respiratory care practitioners and critical care nurses. RESULTS: Seventy-two critically ill pediatric patients were treated with HBOT. Forty-eight (67%) of the patients were male, 24 (33%) were female. Their ages ranged from 15 days to 17 years (mean age: 10 years). HBOT diagnoses included: compromised flaps/grafts (27), refractory osteomyelitis (8), acute traumatic ischemia (7), carbon monoxide poisoning (7), problem wound (7), mucormycosis (5), necrotizing faciitis (6), soft tissue radiation necrosis (2), crush injury (1), mixed soft tissue infection (1) and osteoradionecrosis (1). Critical care devices present or procedures associated with HBOT included: intravenous lines (50), arterial lines (15), ventilators (13), vasopressors (4) and non-invasive blood pressure monitors (2). Side effects associated with the treatments included need for surgical placement of pressure equalizing ear tubes (3), bilateral serous otitis media (1), ear pain (1) and vomiting (1). 60% of patients were successfully treated with HBOT. No deaths were associated with any of the treatments given. CONCLUSIONS: HBOT is an effective treatment for critically ill pediatric patients in the appropriate environment. It was associated with few side effects and no mortality in our patient population. en
dc.format.extent 193 bytes
dc.format.mimetype text/plain
dc.language.iso en en
dc.publisher Undersea and Hyperbaric Medical Society, Inc. en
dc.subject Hyperbaric Oxygenation en
dc.subject children en
dc.subject pediatric en
dc.subject critical care en
dc.subject case review en
dc.subject morbidity en
dc.title [abstract] A 10-YEAR RETROSPECTIVE STUDY OF THE EFFECTIVENESS OF HYPERBARIC OXYGEN THERAPY IN TREATING CRITICALLY ILL PEDIATRIC PATIENTS. en
dc.type Article en

Files in this item

Files Size Format View
abstract.txt 193bytes Text file View/Open

This item appears in the following Collection(s)

  • UHMS Meeting Abstracts
    This is a collection of the published abstracts from the Undersea and Hyperbaric Medical Society (UHMS) annual meetings.

Show simple item record

Browse

My Account